These computational insights complement our biochemical findings, suggesting that NSP‐B's inhibitory effects on the AKT pathway in T‐ALL may stem from its direct interaction and binding stability with AKT. The gene discussed is AKT1; the disease is acute lymphoblastic leukemia.